ADMA Biologics

ADMA Biologics is an end-to-end commercial biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for immune deficiencies and infectious diseases. Its FDA-approved products include ASCENIV, BIVIGAM, and Nabi-HB, produced at a cGMP-compliant manufacturing facility with its own plasma collection centers. The company is publicly traded on NASDAQ under the ticker ADMA.